Abbott Laboratories (NYSE:ABT) Could Be Undervalued Amid Strong Earnings Growth Outlook "Abbott Laboratories has faced recent share price pressure, declining about 13-15% in recent months amid market concerns over segment challenges.… Posted by MJ February 15, 2026
